You are currently on the new version of our website. Access the old version .

5 Results Found

  • Article
  • Open Access
3 Citations
3,334 Views
17 Pages

Identification of a Steric Zipper Motif in the Amyloidogenic Core of Human Cystatin C and Its Use for the Design of Self-Assembling Peptides

  • Emilia Iłowska,
  • Jakub Barciszewski,
  • Mariusz Jaskólski,
  • Augustyn Moliński,
  • Maciej Kozak and
  • Aneta Szymańska

Amyloid fibrils have been known for many years. Unfortunately, their fame stems from negative aspects related to amyloid diseases. Nevertheless, due to their properties, they can be used as interesting nanomaterials. Apart from their remarkable stabi...

  • Review
  • Open Access
13 Citations
4,065 Views
11 Pages

A New Function for Amyloid-Like Interactions: Cross-Beta Aggregates of Adhesins form Cell-to-Cell Bonds

  • Peter N. Lipke,
  • Marion Mathelié-Guinlet,
  • Albertus Viljoen and
  • Yves F. Dufrêne

11 August 2021

Amyloid structures assemble through a repeating type of bonding called “cross-β”, in which identical sequences in many protein molecules form β-sheets that interdigitate through side chain interactions. We review the structural characteristics of suc...

  • Review
  • Open Access
180 Citations
21,150 Views
30 Pages

Structure and Aggregation Mechanisms in Amyloids

  • Zaida L. Almeida and
  • Rui M. M. Brito

The aggregation of a polypeptide chain into amyloid fibrils and their accumulation and deposition into insoluble plaques and intracellular inclusions is the hallmark of several misfolding diseases known as amyloidoses. Alzheimer′s, Parkinson′s and Hu...

  • Review
  • Open Access
52 Citations
10,678 Views
18 Pages

Amyloid fibrils are supramolecular protein assemblies represented by a cross-β structure and fibrous morphology, whose structural architecture has been previously investigated. While amyloid fibrils are basically a main-chain-dominated structure cons...

  • Article
  • Open Access
21 Citations
6,492 Views
20 Pages

Diabetes Drug Discovery: hIAPP1–37 Polymorphic Amyloid Structures as Novel Therapeutic Targets

  • Isaac Fernández-Gómez,
  • Marquiza Sablón-Carrazana,
  • Alberto Bencomo-Martínez,
  • Guadalupe Domínguez,
  • Reyna Lara-Martínez,
  • Nelly F. Altamirano-Bustamante,
  • Luis Felipe Jiménez-García,
  • Karina Pasten-Hidalgo,
  • Rosa Angélica Castillo-Rodríguez and
  • Myriam M. Altamirano-Bustamante
  • + 7 authors

Human islet amyloid peptide (hIAPP1–37) aggregation is an early step in Diabetes Mellitus. We aimed to evaluate a family of pharmaco-chaperones to act as modulators that provide dynamic interventions and the multi-target capacity (native state, cytot...